KALA - Kala Pharmaceuticals GAAP EPS of -$0.45 misses by $0.11 revenue of $1.37M misses by $1.51M
Kala Pharmaceuticals press release (NASDAQ:KALA): Q1 GAAP EPS of -$0.45 misses by $0.11. Non-GAAP net loss was $29.5M. Revenue of $1.37M (-58.1% Y/Y) misses by $1.51M.
For further details see:
Kala Pharmaceuticals GAAP EPS of -$0.45 misses by $0.11, revenue of $1.37M misses by $1.51M